Hiramatsu T, Forbess J M, Miura T, Mayer J E
Department of Cardiac Surgery, Harvard Medical School, Boston, Mass.
J Thorac Cardiovasc Surg. 1995 Jan;109(1):81-6; discussion 87. doi: 10.1016/S0022-5223(95)70423-X.
Myocardial ischemia and reperfusion results in both ventricular and endothelial dysfunction. We have found that the endothelial defect is a reduced vasodilator response to an intraarterial infusion of acetylcholine that is likely due to reduced nitric oxide release, and we have hypothesized that reduced endothelial nitric oxide production contributes to postischemic cardiac dysfunction. However, others report that nitric oxide is deleterious after ischemia. We therefore examined the effects of infusions of L-arginine (3 mmol/L), a precursor of nitric oxide, D-arginine (3 mmol/L), an inactive stereoisomer of L-arginine, L-nitro-arginine methyl ester (1 mmol/L); a competitive inhibitor of nitric oxide synthase, and L-nitro-arginine methyl ester (1 mmol/L) plus L-arginine (3 mmol/L) versus controls in isolated blood-perfused neonatal lamb hearts having 2 hours of cold cardioplegic ischemia. L-nitro-arginine methyl ester was given before reperfusion, and L-arginine and D-arginine were infused for the first 20 minutes of postischemic reperfusion. At 30 minutes of reperfusion, by comparison with the control group, the L-arginine group showed significantly better recovery (p < 0.05) of left ventricular systolic function (maximum developed pressure, developed pressure at V10 [balloon volume to produce an end-diastolic pressure of 10 mm Hg during baseline measurement], positive maximum dP/dt, and dP/dt at V10), diastolic function (negative maximum dP/dt), coronary blood flow, and endothelial function assessed by the coronary vascular resistance response to acetylcholine. The L-nitro-arginine methyl ester hearts showed a significantly poorer recovery (p < 0.05) in left ventricular function, coronary blood flow, and endothelial function than the control group. These effects of L-nitro-arginine methyl ester were reversed to equal control values by adding a 3 mmol/L concentration of L-arginine to L-nitro-arginine methyl ester. There were no significant differences in the recovery of any variables between the D-arginine and control groups. These results point to an important salutary role for the endothelial production of nitric oxide in cardiac recovery after hypothermic ischemia in neonatal lamb hearts. The mechanism of these beneficial effects of L-arginine after ischemia and reperfusion is likely due to enhancement of the endothelial production of nitric oxide.
心肌缺血再灌注会导致心室和内皮功能障碍。我们发现内皮缺陷表现为对动脉内注入乙酰胆碱的血管舒张反应减弱,这可能是由于一氧化氮释放减少所致,并且我们推测内皮一氧化氮生成减少会导致缺血后心脏功能障碍。然而,其他人报告称一氧化氮在缺血后具有有害作用。因此,我们在具有2小时冷停搏缺血的离体血液灌注新生羔羊心脏中,研究了注入一氧化氮前体L - 精氨酸(3 mmol/L)、L - 精氨酸的无活性立体异构体D - 精氨酸(3 mmol/L)、一氧化氮合酶竞争性抑制剂L - 硝基精氨酸甲酯(1 mmol/L)以及L - 硝基精氨酸甲酯(1 mmol/L)加L - 精氨酸(3 mmol/L)与对照组相比的效果。在再灌注前给予L - 硝基精氨酸甲酯,在缺血后再灌注的前20分钟注入L - 精氨酸和D - 精氨酸。在再灌注30分钟时,与对照组相比,L - 精氨酸组左心室收缩功能(最大发展压力、V10时的发展压力[在基线测量期间产生10 mmHg舒张末期压力的球囊容积时的压力]、正最大dP/dt以及V10时的dP/dt)、舒张功能(负最大dP/dt)、冠状动脉血流量以及通过冠状动脉血管阻力对乙酰胆碱的反应评估的内皮功能均显示出明显更好的恢复(p < 0.05)。L - 硝基精氨酸甲酯组的心脏在左心室功能、冠状动脉血流量和内皮功能方面的恢复明显比对照组差(p < 0.05)。通过向L - 硝基精氨酸甲酯中添加3 mmol/L浓度的L - 精氨酸,L - 硝基精氨酸甲酯的这些作用被逆转至与对照组相当的值。D - 精氨酸组和对照组在任何变量的恢复方面均无显著差异。这些结果表明,内皮产生的一氧化氮在新生羔羊心脏低温缺血后的心脏恢复中具有重要的有益作用。缺血再灌注后L - 精氨酸这些有益作用的机制可能是由于内皮一氧化氮生成的增强。